by rdbiomed | Nov 6, 2019 | Company News
The Peptest team headed to the Czech Republic in October to take part in the second annual ‘Peptest Day’ hosted by Imedex. Imedex, our exclusive distributor for the Czech Republic and Slovakia, organised the knowledge-sharing workshop to coincide with the Pneumology... 
by rdbiomed | Nov 5, 2019 | reflux treatments
Doctors in the UK have been told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a ‘precautionary measure’. The Medicines and Healthcare products Regulatory Agency (MHRA) say patients should not stop taking their medication, and... 
by rdbiomed | Oct 15, 2019 | reflux treatments
Alginate, a type of fibre found in seaweed, has been used to help with the symptoms of reflux disease for many years. Alginates naturally occur as structural polysaccharides in brown algae and have a unique mode of action, producing a ‘raft’. This gel raft floats on... 
by rdbiomed | Sep 17, 2019 | LPR
Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month. The Cutting Edge Laryngology Conference showcases the most up-to-date advances in... 
by rdbiomed | Sep 9, 2019 | Company News
The Peptest team has headed to China this week to finalise plans for the official launch of our reflux diagnostic device in the world’s most populous country. In an exciting development for Peptest, we’re thrilled to reveal that following years of intensive research,...
Recent Comments